Guangdong Transtek Medical Electronics Co., Ltd Stock

Equities

300562

CNE100002DJ6

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
8.71 CNY -1.80% Intraday chart for Guangdong Transtek Medical Electronics Co., Ltd +1.04% -23.66%
Sales 2024 * 1.15B 158M Sales 2025 * 1.47B 203M Capitalization 1.92B 265M
Net income 2024 * 55M 7.59M Net income 2025 * 71M 9.8M EV / Sales 2024 * 1.68 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.31 x
P/E ratio 2024 *
34.8 x
P/E ratio 2025 *
26.9 x
Employees 1,286
Yield 2024 *
0.45%
Yield 2025 *
0.56%
Free-Float 62.75%
More Fundamentals * Assessed data
Dynamic Chart
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transtek Medical Electronics Gets Nod to Sell Blood Pressure Monitoring Device in Canada MT
Tranche Update on Guangdong Transtek Medical Electronics Co., Ltd's Equity Buyback Plan announced on February 1, 2024. CI
Guangdong Transtek Medical Electronics Co., Ltd Proposes Final Cash Dividend for the Year 2023 CI
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Guangdong Transtek Medical Electronics Co., Ltd announces an Equity Buyback for CNY 40 million worth of its shares. CI
Guangdong Transtek Medical Electronics Co., Ltd authorizes a Buyback Plan. CI
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangdong Transtek Medical Electronics Co., Ltd agreed to acquire the remaining 49% stake in Lifesense Medical Treatment Remote Technology Co., Ltd. from Pan Nongfei and Wu Zhu for CNY 2 CI
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Transtek Medical Electronics Registers Electronic Blood Pressure Monitor in China MT
Guangdong Transtek Medical Electronics Co., Ltd Approves the Cash Dividend for 2022, Payable on 9 June 2023 CI
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Guangdong Transtek Medical Electronics Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day+4.85%
1 week+2.90%
Current month-7.89%
1 month-6.14%
3 months-10.40%
6 months-17.79%
Current year-22.26%
More quotes
1 week
8.02
Extreme 8.02
8.87
1 month
7.52
Extreme 7.52
9.78
Current year
5.94
Extreme 5.94
12.37
1 year
5.94
Extreme 5.94
13.00
3 years
5.94
Extreme 5.94
18.80
5 years
5.94
Extreme 5.94
26.20
10 years
5.86
Extreme 5.8625
52.34
More quotes
Managers TitleAgeSince
Director of Finance/CFO 47 23-01-18
President 42 23-07-25
Chairman 52 02-12-31
Members of the board TitleAgeSince
Director/Board Member 43 22-05-26
Chairman 51 12-11-15
Chairman 52 02-12-31
More insiders
Date Price Change Volume
24-04-24 8.71 -1.80% 10 582 700
24-04-24 8.87 +4.85% 6,816,300
24-04-23 8.46 +1.68% 6,157,820
24-04-22 8.32 +0.85% 6,188,945
24-04-19 8.25 -0.12% 5,111,399

End-of-day quote Shenzhen S.E., April 23, 2024

More quotes
Guangdong Transtek Medical Electronics Co., Ltd. is a China-based company principally engaged in the research, design, manufacture and distribution of home health care electronic products, as well as the research and operation of an intelligent health cloud platform. The Company’s products include electronic kitchen scales, health scales, fat determination systems, electronic sphygmomanometers, smart watches and wearable intelligent wristbands. The Company is also involved in the development of mobile applications (apps). It application, Lexin Sport, is able to tracker the steps, weight, heart rate and sleeping condition of the user. The Company distributes its products in domestic market and to overseas markets.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.87 CNY
Average target price
12.75 CNY
Spread / Average Target
+43.74%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300562 Stock